AZP2006 in Parkinson’s disease models: A promising new neuroprotective treatment involving lysosomal homeostasis and the Progranulin/Prosaposin complex
Noelle Callizot, Georgia Culley, Grace Flower, Laura Rouvière, Véronique De Conto, Alexandre Wojcinski, Catherine Botto, Cecilia Estrella · 2026
Read AZP2006 in Parkinson’s disease models: A promising new neuroprotective treatment involving lysosomal homeostasis and the Progranulin/Prosaposin complex by Noelle Callizot, Georgia Culley, Grace Flower, Laura Rouvière, Véronique De Conto, Alexandre Wojcinski, Catherine Botto, Cecilia Estrella (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0359269.txt.
Description
Callizot and seven co-authors published a 2026 PLOS ONE study on a possible new drug for Parkinson's disease. The compound, called AZP2006, was tested in lab models of the disease. The title calls it a promising protective treatment for nerve cells. Its action involves lysosomes, the cell's cleanup units, and a protein pair named progranulin and prosaposin. New ways to slow Parkinson's are badly needed.
Catalog record
| CREATOR | Noelle Callizot, Georgia Culley, Grace Flower, Laura Rouvière, Véronique De Conto, Alexandre Wojcinski, Catherine Botto, Cecilia Estrella |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51054 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |